Advanced BioMedical Technologies (Advanced BioMedical Technologies) Price-to-Operating-Cash-Flow : (As of Apr. 26, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Advanced BioMedical Technologies Price-to-Operating-Cash-Flow?

As of today (2024-04-26), Advanced BioMedical Technologies's share price is $0.0006. Advanced BioMedical Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jul. 2021 was $0.00. Hence, Advanced BioMedical Technologies's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Advanced BioMedical Technologies's Price-to-Operating-Cash-Flow or its related term are showing as below:

ABMT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 21.02
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Advanced BioMedical Technologies's Cash Flow from Operations per share for the three months ended in Jul. 2021 was $-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jul. 2021 was $0.00.

Advanced BioMedical Technologies Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Advanced BioMedical Technologies's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced BioMedical Technologies Price-to-Operating-Cash-Flow Chart

Advanced BioMedical Technologies Annual Data

Trend

Oct11

Oct12

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

16.67

Advanced BioMedical Technologies Quarterly Data
	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	16.67	57.67	45.30	-

Competitive Comparison of Advanced BioMedical Technologies's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Advanced BioMedical Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced BioMedical Technologies's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's Price-to-Operating-Cash-Flow falls into.

Advanced BioMedical Technologies Price-to-Operating-Cash-Flow Calculation

Advanced BioMedical Technologies's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.0006	/	0.001
	=

Advanced BioMedical Technologies's Share Price of today is $0.0006.
Advanced BioMedical Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jul. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Advanced BioMedical Technologies Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Advanced BioMedical Technologies's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced BioMedical Technologies (Advanced BioMedical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced BioMedical Technologies Inc (OTCPK:ABMT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Park Avenue, Suite 1700, New York, NY, USA, 10166

Website

https://www.abtbiomedical.com

Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.

Executives

Advanced Biomedical Technologies Inc.	director, officer: CFO	200 PARK AVENUE, SUITE 1700 NEW YORK NY 10166
Lynch John Thomas Jr	other: Advisor	22 MULBERRY STREET SUITE 1B MIDDLETOWN NY 10940
Chi Ming Yu	director, 10 percent owner, officer: PRESIDENT	36 CLAREMONT TERRACE WAYNE NJ 07470
Andriy Protskiv	director, 10 percent owner, officer: President, CEO, CFO	706-15038 101 AVENUE SURREY A1 V3R 0N2

Advanced BioMedical Technologies (Advanced BioMedical Technologies) Headlines

From GuruFocus

Advanced Biomedical Technologies Inc. Announces Chinese CFDA Approval of Polymer Fixation Screws

By Marketwired Marketwired • 04-19-2018

Advanced Biomedical Technologies Inc. Launches Sales Campaign

By Marketwired Marketwired • 11-06-2019